Using proteomic approaches to identify new biomarkers for detection and monitoring of ovarian cancer

Cannistra, 2004, Cancer of the ovary, N. Engl. J. Med., 351, 2519, 10.1056/NEJMra041842 Schildkraut, 1988, Familial ovarian cancer: a population based case-control study, Am. J. Epidemiol., 128, 456, 10.1093/oxfordjournals.aje.a114994 Ries, 1999 Bast, 1998, CA 125: the past and the future, Int. J. Biol. Markers, 13, 179, 10.1177/172460089801300402 Jacobs, 1996, Risk of diagnosis of ovarian cancer after raised serum CA 125 concentration: a prospective cohort study, BMJ, 313, 1355, 10.1136/bmj.313.7069.1355 Jacobs, 1989, The CA-125 tumor associated antigen: a review of the literature, Hum. Reprod., 4, 1, 10.1093/oxfordjournals.humrep.a136832 Rustin, 2004, Can we now agree to use the same definition to measure response according to CA-125?, J. Clin. Oncol., 22, 4035, 10.1200/JCO.2004.06.628 Torizuka, 2002, Ovarian cancer recurrence: role of whole-body positron emission tomography using 2-[fluorine-18]-fluoro-2-deoxy-d-glucose, Eur. J. Nucl. Med. Mol. Imaging, 29, 797, 10.1007/s00259-001-0750-9 Jungblut, 1999, Proteomics in human disease: cancer, heart and infectious diseases, Electrophoresis, 20, 2100, 10.1002/(SICI)1522-2683(19990701)20:10<2100::AID-ELPS2100>3.0.CO;2-D Banks, 2000, Proteomics: new perspective, new biomedical opportunities, Lancet, 356, 1749, 10.1016/S0140-6736(00)03214-1 Petricoin, 2002, Use of proteomic patterns in serum to identify ovarian cancer, Lancet, 359, 572, 10.1016/S0140-6736(02)07746-2 Espina, 2004, Use of proteomic analysis to monitor responses to biological therapies, Expert Opin. Biol. Ther., 4, 83, 10.1517/14712598.4.1.83 Zhang, 2004, Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer, Cancer Res., 64, 5882, 10.1158/0008-5472.CAN-04-0746 Ardekani, 2002, Clinical potential of proteomics in the diagnosis of ovarian cancer, Expert Rev. Mol. Diagn., 2, 312, 10.1586/14737159.2.4.312 Banerjee, 2004, Search for a novel biomarker for the brain cancer astrocytoma by using surface enhanced laser desorption/ionisation (SELDI) technique, Cell. Mol. Biol. (Noisy-le-grand), 50, 733 Ebert, 2004, Identification of gastric cancer patients by serum protein profiling, J. Proteome Res., 3, 1261, 10.1021/pr049865s Baggerly, 2004, Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments, Bioinformatic, 20, 777, 10.1093/bioinformatics/btg484